Demecarium

DB00944ApprovedSmall molecule

Demecarium is an indirect-acting parasympathomimetic agent that is used to treat glaucoma. It is a cholinesterase inhibitor or an anticholinesterase. Cholinesterase inhibitors prolong the effect of acetylcholine, which is released... Cholinesterase inhibitors prolong the effect of acetylcholine, which is released at the neuroeffector junction of parasympathetic postganglion nerves, by inactivating the cholinesterases that break it down.

Chemical structure of Demecarium
Mechanism
Curator reviewed
Primary indication
For the topical treatment of chronic open-angle glaucoma.Curator reviewed
Formula / weight
C32H52N4O4 · 556.7797 g/mol (avg)
Also known as
Demecarium ion

Resolves to

Structure
InChIKeyRWZVPVOZTJJMNU-UHFFFAOYSA-NSMILESCN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
292Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Demecarium, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account